Towards Optimization of Ureteral Health and Improvement of Outcomes During Semirigid Ureteroscopy: 4.5/6 Fr vs. 6/7.5 Fr Ureteroscopes a randomized trial
Phase 4
Completed
- Conditions
- Urological and Genital Diseases
- Registration Number
- PACTR202102518224713
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 198
Inclusion Criteria
1st episode of ureteric (middle or lower) radiopaque stones, after the failure of medical expulsive therapy,
Exclusion Criteria
We excluded patients with multiple or bilateral ureteral stones, coagulation disorders, radiolucent stones, children (age <18years), and previous ureteric intervention including ureteroscopy or ureteric stent insertion. BMI >30
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method